| __timestamp | Agios Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 7461000 |
| Thursday, January 1, 2015 | 35992000 | 13047000 |
| Friday, January 1, 2016 | 50714000 | 11253000 |
| Sunday, January 1, 2017 | 71124000 | 13933000 |
| Monday, January 1, 2018 | 114145000 | 29514000 |
| Tuesday, January 1, 2019 | 132034000 | 37121000 |
| Wednesday, January 1, 2020 | 149070000 | 67929000 |
| Friday, January 1, 2021 | 121445000 | 118818000 |
| Saturday, January 1, 2022 | 121673000 | 159371000 |
| Sunday, January 1, 2023 | 119903000 | 213894000 |
| Monday, January 1, 2024 | 156784000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have been navigating this challenge since 2014. Over the years, Agios has seen a steady increase in SG&A costs, peaking in 2020 with a 680% rise from 2014. Meanwhile, BioCryst's expenses surged dramatically, especially between 2021 and 2023, with a staggering 2,765% increase from 2014.
While Agios maintained a more consistent growth, BioCryst's recent spike suggests aggressive expansion or strategic shifts. This data highlights the importance of cost management in sustaining growth and competitiveness. As these companies continue to innovate, their ability to optimize SG&A expenses will be pivotal in determining their long-term success.
Novo Nordisk A/S vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Bristol-Myers Squibb Company or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Incyte Corporation vs BioCryst Pharmaceuticals, Inc.
Alkermes plc or Agios Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Agios Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and MannKind Corporation
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: SG&A Expense Trends